Cynthia Harden1, Torbjörn Tomson2, David Gloss3, Jeffrey Buchhalter4, J Helen Cross5, Elizabeth Donner6, Jacqueline A French7, Anthony Gil-Nagel8, Dale C Hesdorffer9, W Henry Smithson10, Mark C Spitz11, Thaddeus S Walczak12, Josemir W Sander13, Philippe Ryvlin14. 1. Department of Neurology, Mount Sinai Health System, New York, NY. 2. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. 3. Department of Neurology, CAMC Physicians, Charleston, WV. 4. Alberta Children's Hospital, Departments of Pediatrics and Clinical Neurosciences, University of Calgary, Calgary, Canada. 5. Department of Clinical Neurosciences, University College London - Institute of Child Health, and Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. 6. Division of Neurology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. 7. Department of Neurology, New York University Langone Comprehensive Epilepsy Center, New York, NY. 8. Department of Neurology, Hospital Ruber Internacional, Madrid, Spain. 9. Gertrude H. Sergievsky Center and Department of Epidemiology, Columbia University Medical Center, New York, NY. 10. Department of General Practice, University College Cork, Cork, Ireland. 11. Anschutz Outpatient Pavilion, University of Colorado Health, Aurora, CO. 12. Neurology Clinic, University of Minnesota, Minneapolis, MN. 13. University College London Institute of Neurology, London, United Kingdom, and Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands. 14. Department of Clinical Neurosciences, CHUV, Lausanne, Switzerland.
Abstract
OBJECTIVE: To determine the incidence rates of sudden unexpected death in epilepsy (SUDEP) in different epilepsy populations and address the question of whether risk factors for SUDEP have been identified. METHODS: Systematic review of evidence; modified Grading Recommendations Assessment, Development and Evaluation process for developing conclusions; recommendations developed by consensus. RESULTS: Findings for incidence rates based on 12 Class I studies include the following: SUDEP risk in children with epilepsy (aged 0-17 years) is 0.22/1,000 patient-years (95% CI 0.16-0.31) (high confidence in evidence). SUDEP risk increases in adults to 1.2/1,000 patient-years (95% CI 0.64-2.32) (low confidence in evidence). The major risk factor for SUDEP is the occurrence of generalized tonic-clonic seizures (GTCS); the SUDEP risk increases in association with increasing frequency of GTCS occurrence (high confidence in evidence). RECOMMENDATIONS: Level B: Clinicians caring for young children with epilepsy should inform parents/guardians that in 1 year, SUDEP typically affects 1 in 4,500 children; therefore, 4,499 of 4,500 children will not be affected. Clinicians should inform adult patients with epilepsy that SUDEP typically affects 1 in 1,000 adults with epilepsy per year; therefore, annually 999 of 1,000 adults will not be affected. For persons with epilepsy who continue to experience GTCS, clinicians should continue to actively manage epilepsy therapies to reduce seizures and SUDEP risk while incorporating patient preferences and weighing the risks and benefits of any new approach. Clinicians should inform persons with epilepsy that seizure freedom, particularly freedom from GTCS, is strongly associated with decreased SUDEP risk.
OBJECTIVE: To determine the incidence rates of sudden unexpected death in epilepsy (SUDEP) in different epilepsy populations and address the question of whether risk factors for SUDEP have been identified. METHODS: Systematic review of evidence; modified Grading Recommendations Assessment, Development and Evaluation process for developing conclusions; recommendations developed by consensus. RESULTS: Findings for incidence rates based on 12 Class I studies include the following: SUDEP risk in children with epilepsy (aged 0-17 years) is 0.22/1,000 patient-years (95% CI 0.16-0.31) (high confidence in evidence). SUDEP risk increases in adults to 1.2/1,000 patient-years (95% CI 0.64-2.32) (low confidence in evidence). The major risk factor for SUDEP is the occurrence of generalized tonic-clonic seizures (GTCS); the SUDEP risk increases in association with increasing frequency of GTCS occurrence (high confidence in evidence). RECOMMENDATIONS: Level B: Clinicians caring for young children with epilepsy should inform parents/guardians that in 1 year, SUDEP typically affects 1 in 4,500 children; therefore, 4,499 of 4,500 children will not be affected. Clinicians should inform adult patients with epilepsy that SUDEP typically affects 1 in 1,000 adults with epilepsy per year; therefore, annually 999 of 1,000 adults will not be affected. For persons with epilepsy who continue to experience GTCS, clinicians should continue to actively manage epilepsy therapies to reduce seizures and SUDEP risk while incorporating patient preferences and weighing the risks and benefits of any new approach. Clinicians should inform persons with epilepsy that seizure freedom, particularly freedom from GTCS, is strongly associated with decreased SUDEP risk.
Authors: Philippe Ryvlin; Lina Nashef; Samden D Lhatoo; Lisa M Bateman; Jonathan Bird; Andrew Bleasel; Paul Boon; Arielle Crespel; Barbara A Dworetzky; Hans Høgenhaven; Holger Lerche; Louis Maillard; Michael P Malter; Cecile Marchal; Jagarlapudi M K Murthy; Michael Nitsche; Ekaterina Pataraia; Terje Rabben; Sylvain Rheims; Bernard Sadzot; Andreas Schulze-Bonhage; Masud Seyal; Elson L So; Mark Spitz; Anna Szucs; Meng Tan; James X Tao; Torbjörn Tomson Journal: Lancet Neurol Date: 2013-09-04 Impact factor: 44.182
Authors: Samden D Lhatoo; Howard J Faulkner; Krystina Dembny; Kathy Trippick; Claire Johnson; Jonathan M Bird Journal: Ann Neurol Date: 2010-12 Impact factor: 10.422
Authors: Anders Gaarsdal Holst; Bo Gregers Winkel; Bjarke Risgaard; Jonas Bille Nielsen; Peter Vibe Rasmussen; Stig Haunsø; Anne Sabers; Peter Uldall; Jacob Tfelt-Hansen Journal: Epilepsia Date: 2013-07-29 Impact factor: 5.864
Authors: Anne T Berg; Katherine Nickels; Elaine C Wirrell; Ada T Geerts; Petra M C Callenbach; Willem F Arts; Christina Rios; Peter R Camfield; Carol S Camfield Journal: Pediatrics Date: 2013-06-10 Impact factor: 7.124
Authors: Sara Zak; Nadine Mokhallati; Weiji Su; Francis X McCormack; David N Franz; Maxwell Mays; Darcy A Krueger; Rhonda D Szczesniak; Nishant Gupta Journal: Ann Am Thorac Soc Date: 2019-04
Authors: Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke Journal: Pediatr Neurol Date: 2019-02-23 Impact factor: 3.372